Clinical trial
Statin Therapy in Heart Failure: Potential Mechanisms of Benefit
NCT00233480 · University of California, Los Angeles, Other · Completed
Key facts
| NCT number | NCT00233480 |
|---|---|
| Title | Statin Therapy in Heart Failure: Potential Mechanisms of Benefit |
| Official title | A Double-blind Randomized, Placebo-Controlled, Single-Center Study to Assess the Impact of Statins on the Autonomic Nervous System and Cardiac Structure/Function in Non-Ischemic Heart Failure |
| Lead sponsor | University of California, Los Angeles, Other |
| Collaborators | Pfizer Industry National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Heart Failure, Congestive |
| Intervention type | Drug |
| Interventions | atorvastatin, placebo |
| Enrollment | 27 |
| Start date | Aug 1, 2005 |
| Primary completion | Feb 1, 2009 |
| Completion | Feb 1, 2009 |
| First posted | Oct 5, 2005 |
| Last update posted | Mar 20, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: